Copa Star: High-value Healthcare For Brazilians

Copa Star, the high-quality hospital located at Copacabana, Rio de Janeiro, is known for excellent health care services in a luxurious ambiance. The hospital has well-trained staff, high-quality physicians, and latest technology to care each of its patients personally. The hospital spans in a 21,000-meter square area, and it has seven floors. It provides the latest treatments in Cardiac Surgery and Neurosurgery with latest and sophisticated techniques to ensure the full recovery of the patients. The hospital is inaugurated in November 2016, and it is located in the proximity of famous Copacabana beach. The hospital group is planning to expand this successful model to other parts of the country. It has initiated the projects in Brasília and São Paulo.

The Rede D’Or São Luiz Network hospital building is an example of state of the art architecture with natural light is entering almost all the rooms. The walls of the hospital are decorated by the paintings of Yutaka Toyota. The hospital is giving an impression of a five-star hotel with the options and amenities it provides along with world-class healthcare. The hospital has 550 employees including 113 physicians to serve the patients with utmost care. The employees are getting trained on how to behave professionally to the patients and their relatives. The hospital is also giving special two months training for the new employees to help them experienced with the latest technologies, machines, diagnosis methods, tests etc.

D “Or São Luiz Network, the hospital group has partnered with The D’Or Institute for Research and Education (IDOR), an institution set up for the technological and scientific advancement and training to various healthcare professionals. The non-profit institution started its operations in 2010 and its campus in Rio de Janeiro provide a wide range of options and training include detailed research in medicine and surgery. They use the resources and technical excellence of Rede D’Or São Luiz hospitals including Copa Star. IDOR also coordinates with the training and research activities of the network hospitals in Brasilia, São Paulo, Rio de Janeiro, and Recife. The IDOR research team includes 17 researchers and at least 50 students in various researches in the institution which are in the areas of Internal Medicine, Pediatrics, Intensive Care Medicine, Oncology, and Neurosciences.

With the help of Rede D’Or São Luiz, IDOR provides various courses like Residency programs that include graduation and post-graduation, and other improvements, specialization and updating courses. The post-graduation and doctoral programs such as UFRJ, UERJ, INCA, and FIOCRUZ are aimed to improve the research, clinical, and surgical capabilities of both researchers and students. Additionally, it conducts various seminars, lectures, workshops, etc., to increase the exposure of the students by bringing latest changes in medicine, surgery, and technology. The institute also brings international delegates and guests for the events to encourage a collaboration of researchers from worldwide.

Read more at SSC Magazine about Copa Star.

Building Companies – JeanMarie Guenot


JeanMarie Guenot has a desire to build companies. Her background starts twenty years ago with a mix of both the technical and the business side. She was a principle scientist at Hoffman-La Roche where she developed drugs for various conditions, specifically for metabolic diseases, oncology and autoimmune diseases. LinkedIn paints a picture of a JeanMarie Guenot that is a highly trained individual gaining her Ph.D. from the University of California, San Francisco. Even through her college years, she learned how to build medications, using physics to incorporate into drug design and molecular dynamics. This was the bulk of her training and experience in the technical side.


As is with natural progression, her website indicates JeanMarie transitioned into the business side taking her experience and using it for what the consumer is looking for. She worked at Atlas Venture where she worked with venture capitalists to build science companies. This will be the path she continues on designing and discovering different drugs that will help people. Another milestone in her career was founding SKS Ocular, where they developed ocular drug delivery techniques among other eye related issues. Currently, she works for Amphivena Therapeutics as their President and CEO. The company is “developing innovative bifunctional antibody therapies for hematologic malignancies.” Amphivena Therapeutics are developing an antigen for blood cancer and evaluating many areas which have medical needs.


The journey she has been over the years has been a benefit for generations to come. “Restoring the flow of life” is a phrase used at Amphivena Therapeutics. The research and development ongoing with this brain trust is to help the greater good from blood cancers, catching it before the illness develops too far. This is a great endeavor, even though results are time-consuming and difficult to come by. She continues to invest and build in companies for the greater good. Her collaborative outlook and the partnerships she builds in conjunction with her dynamic leadership team leads to another successful company building process.